US6767510B1
(en)
|
1992-05-21 |
2004-07-27 |
Biosite, Inc. |
Diagnostic devices and apparatus for the controlled movement of reagents without membranes
|
US6905882B2
(en)
*
|
1992-05-21 |
2005-06-14 |
Biosite, Inc. |
Diagnostic devices and apparatus for the controlled movement of reagents without membranes
|
US6113855A
(en)
*
|
1996-11-15 |
2000-09-05 |
Biosite Diagnostics, Inc. |
Devices comprising multiple capillarity inducing surfaces
|
US6194222B1
(en)
*
|
1998-01-05 |
2001-02-27 |
Biosite Diagnostics, Inc. |
Methods for monitoring the status of assays and immunoassays
|
US7713703B1
(en)
|
2000-11-13 |
2010-05-11 |
Biosite, Inc. |
Methods for monitoring the status of assays and immunoassays
|
US7914994B2
(en)
*
|
1998-12-24 |
2011-03-29 |
Cepheid |
Method for separating an analyte from a sample
|
US6319719B1
(en)
*
|
1999-10-28 |
2001-11-20 |
Roche Diagnostics Corporation |
Capillary hematocrit separation structure and method
|
US6720157B2
(en)
*
|
2000-02-23 |
2004-04-13 |
Zyomyx, Inc. |
Chips having elevated sample surfaces
|
AU2002231736A1
(en)
|
2000-12-22 |
2002-07-08 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
US7713705B2
(en)
*
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
US7524635B2
(en)
*
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
US20040126767A1
(en)
*
|
2002-12-27 |
2004-07-01 |
Biosite Incorporated |
Method and system for disease detection using marker combinations
|
US20030219734A1
(en)
*
|
2001-04-13 |
2003-11-27 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
US20030199000A1
(en)
*
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20040121350A1
(en)
*
|
2002-12-24 |
2004-06-24 |
Biosite Incorporated |
System and method for identifying a panel of indicators
|
US20040253637A1
(en)
*
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
US20040203083A1
(en)
*
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
US7632647B2
(en)
|
2001-04-13 |
2009-12-15 |
Biosite Incorporated |
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
|
DE60233301D1
(de)
|
2001-05-04 |
2009-09-24 |
Biosite Inc |
Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs
|
US6759009B2
(en)
|
2001-05-04 |
2004-07-06 |
Portascience Incorporated |
Method and device for clotting time assay
|
US20040219509A1
(en)
*
|
2001-08-20 |
2004-11-04 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
EP1419388B1
(de)
*
|
2001-08-20 |
2009-10-07 |
Biosite Incorporated |
Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
|
US6919058B2
(en)
*
|
2001-08-28 |
2005-07-19 |
Gyros Ab |
Retaining microfluidic microcavity and other microfluidic structures
|
WO2003060505A1
(en)
*
|
2002-01-04 |
2003-07-24 |
Board Of Regents, The University Of Texas System |
Wall-less channels for fluidic routing and confinement
|
US7459127B2
(en)
*
|
2002-02-26 |
2008-12-02 |
Siemens Healthcare Diagnostics Inc. |
Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
|
US7485453B2
(en)
*
|
2002-05-03 |
2009-02-03 |
Kimberly-Clark Worldwide, Inc. |
Diffraction-based diagnostic devices
|
US7214530B2
(en)
|
2002-05-03 |
2007-05-08 |
Kimberly-Clark Worldwide, Inc. |
Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
|
US7118855B2
(en)
*
|
2002-05-03 |
2006-10-10 |
Kimberly-Clark Worldwide, Inc. |
Diffraction-based diagnostic devices
|
US7771922B2
(en)
|
2002-05-03 |
2010-08-10 |
Kimberly-Clark Worldwide, Inc. |
Biomolecule diagnostic device
|
KR100480338B1
(ko)
*
|
2002-08-08 |
2005-03-30 |
한국전자통신연구원 |
극소량의 유체제어를 위한 미세 유체제어소자
|
US7169550B2
(en)
*
|
2002-09-26 |
2007-01-30 |
Kimberly-Clark Worldwide, Inc. |
Diffraction-based diagnostic devices
|
KR100444751B1
(ko)
*
|
2002-11-11 |
2004-08-16 |
한국전자통신연구원 |
표면장력에 의한 유체제어 소자
|
JP4253178B2
(ja)
*
|
2002-12-02 |
2009-04-08 |
アークレイ株式会社 |
分析用具の製造方法
|
EP1616181B1
(de)
|
2003-04-17 |
2009-08-12 |
Vermillion, Inc. |
Mit natriuretischen peptiden verwandte polypeptide und verfahren zu ihrer identifizierung und verwendung
|
US7435381B2
(en)
*
|
2003-05-29 |
2008-10-14 |
Siemens Healthcare Diagnostics Inc. |
Packaging of microfluidic devices
|
US7582472B2
(en)
*
|
2003-08-26 |
2009-09-01 |
Smith Kenneth E |
Apparatus and method for liquid sample testing
|
EP1673465A4
(de)
*
|
2003-09-29 |
2008-04-30 |
Biosite Inc |
Verfahren und zusammensetzungen zur sepsisdiagnose
|
DE10354806A1
(de)
*
|
2003-11-21 |
2005-06-02 |
Boehringer Ingelheim Microparts Gmbh |
Probenträger
|
DE10360220A1
(de)
*
|
2003-12-20 |
2005-07-21 |
Steag Microparts Gmbh |
Mikrostrukturierte Anordnung zur blasenfreien Befüllung zumindest eines Systems zur Ableitung von Flüssigkeiten, Vorrichtung mit einer solchen Anordnung und Befüllungsverfahren
|
US7632687B2
(en)
*
|
2004-03-23 |
2009-12-15 |
Quidel Corporation |
Hybrid phase lateral flow assay
|
SE0400662D0
(sv)
*
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
US20060105419A1
(en)
*
|
2004-08-16 |
2006-05-18 |
Biosite, Inc. |
Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
|
WO2006022487A1
(en)
*
|
2004-08-21 |
2006-03-02 |
Lg Chem. Ltd. |
Microfluidic device, and diagnostic and analytical apparatus using the same
|
EP1794588A2
(de)
*
|
2004-09-09 |
2007-06-13 |
Biosite Incorporated |
Verfahren und zusammensetzungen zur messung von hunde-bnp und verwendungen davon
|
US20080050832A1
(en)
*
|
2004-12-23 |
2008-02-28 |
Buechler Kenneth F |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
WO2006078813A2
(en)
*
|
2005-01-21 |
2006-07-27 |
Biosite Incorporated |
Arginine analogs, and methods for their synthesis and use
|
US7300631B2
(en)
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
US7611908B2
(en)
|
2005-05-02 |
2009-11-03 |
Bioscale, Inc. |
Method and apparatus for therapeutic drug monitoring using an acoustic device
|
US7648844B2
(en)
|
2005-05-02 |
2010-01-19 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using an acoustic device
|
US7749445B2
(en)
|
2005-05-02 |
2010-07-06 |
Bioscale, Inc. |
Method and apparatus for analyzing bioprocess fluids
|
JP2008544224A
(ja)
*
|
2005-06-09 |
2008-12-04 |
バイオサイト インコーポレイテッド |
静脈血栓塞栓症の診断のための方法および組成物
|
SE529254C2
(sv)
*
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
EP1929295A4
(de)
*
|
2005-08-30 |
2010-03-17 |
Biosite Inc |
Verwendung von löslichem flt-1 und seiner fragmente bei herz-kreislauf-leiden
|
ES2542501T3
(es)
|
2005-09-30 |
2015-08-06 |
Abbvie Deutschland Gmbh & Co Kg |
Dominios de unión de proteínas de la familia de proteínas de moléculas de orientación repulsiva (RGM) y fragmentos funcionales de las mismas, así como su uso
|
US8133741B2
(en)
|
2005-10-26 |
2012-03-13 |
General Electric Company |
Methods and systems for delivery of fluidic samples to sensor arrays
|
US7723120B2
(en)
*
|
2005-10-26 |
2010-05-25 |
General Electric Company |
Optical sensor array system and method for parallel processing of chemical and biochemical information
|
US7794656B2
(en)
|
2006-01-23 |
2010-09-14 |
Quidel Corporation |
Device for handling and analysis of a biological sample
|
US7871568B2
(en)
|
2006-01-23 |
2011-01-18 |
Quidel Corporation |
Rapid test apparatus
|
EP2005168A4
(de)
*
|
2006-03-09 |
2009-05-20 |
Biosite Inc |
Verfahren und zusammensetzung zur diagnose von krankheiten der aorta
|
US20080118924A1
(en)
*
|
2006-05-26 |
2008-05-22 |
Buechler Kenneth F |
Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
|
GB0611116D0
(en)
|
2006-06-06 |
2006-07-19 |
Oxford Genome Sciences Uk Ltd |
Proteins
|
US20110287010A1
(en)
|
2006-06-07 |
2011-11-24 |
Otago Innovation Limited |
Diagnostic methods and markers
|
EP2049902A4
(de)
*
|
2006-07-28 |
2010-09-01 |
Biosite Inc |
Vorrichtung und verfahren zur durchführung von rezeptorbindungstests mithilfe magnetischer partikel
|
CN101611318B
(zh)
|
2006-09-07 |
2015-03-04 |
奥塔哥创新有限公司 |
生物标记物
|
WO2008061149A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Biosite Incorporated |
Methods and compositions for diagnosis and prognosis of renal artery stenosis
|
EP2095107B1
(de)
|
2006-11-14 |
2014-07-02 |
Alere San Diego, Inc. |
Verfahren zur risikoabschätzung
|
US20080118402A1
(en)
*
|
2006-11-21 |
2008-05-22 |
David Brancazio |
Method and apparatus for analyte processing
|
US8202491B2
(en)
*
|
2006-11-21 |
2012-06-19 |
Bioscale, Inc. |
Apparatus for analyte processing
|
US20090004755A1
(en)
*
|
2007-03-23 |
2009-01-01 |
Biosite, Incorporated |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
US8221995B2
(en)
*
|
2007-03-23 |
2012-07-17 |
Seok-Won Lee |
Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
|
EP1977829A1
(de)
*
|
2007-03-29 |
2008-10-08 |
Roche Diagnostics GmbH |
Vorrichtung zur parallelen Durchführung mehrerer Analysen
|
US7883898B2
(en)
*
|
2007-05-07 |
2011-02-08 |
General Electric Company |
Method and apparatus for measuring pH of low alkalinity solutions
|
US20080295909A1
(en)
*
|
2007-05-24 |
2008-12-04 |
Locascio Laurie E |
Microfluidic Device for Passive Sorting and Storage of Liquid Plugs Using Capillary Force
|
WO2009033056A1
(en)
|
2007-09-06 |
2009-03-12 |
Bioscale, Inc. |
Reusable detection surfaces and methods of using same
|
EP2200744B1
(de)
|
2007-09-14 |
2020-05-27 |
Biosensia Patents Limited |
Analysesystem
|
US8241589B2
(en)
*
|
2008-02-01 |
2012-08-14 |
Nippon Telegraph And Telephone Corporation |
Flow cell
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
ES2666725T3
(es)
|
2008-03-12 |
2018-05-07 |
Otago Innovation Limited |
Biomarcadores
|
JP2011516038A
(ja)
|
2008-03-12 |
2011-05-26 |
オタゴ イノベーション リミテッド |
バイオマーカー
|
SE533514C2
(sv)
*
|
2008-06-16 |
2010-10-12 |
Aamic Ab |
Analysanordning och förfarande
|
CN102187220B
(zh)
|
2008-08-28 |
2015-08-19 |
阿斯图特医药公司 |
用于诊断和预后肾损伤和肾衰竭的方法和组合物
|
JP5947544B2
(ja)
|
2008-08-29 |
2016-07-06 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後のための方法および組成物
|
EP2172260A1
(de)
*
|
2008-09-29 |
2010-04-07 |
Corning Incorporated |
Mehrflussweg-Mikroflüssigkeitsvorrichtungen
|
NZ619918A
(en)
|
2008-10-21 |
2015-04-24 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CA2740788C
(en)
|
2008-10-21 |
2023-03-14 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
JP5981140B2
(ja)
|
2008-11-07 |
2016-08-31 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
光度反応フィルム用微粒子充填物質
|
AU2009313189B2
(en)
|
2008-11-10 |
2014-10-23 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
ES2528799T3
(es)
|
2008-11-22 |
2015-02-12 |
Astute Medical, Inc. |
Métodos para el pronóstico de insuficiencia renal aguda
|
US20100204055A1
(en)
*
|
2008-12-05 |
2010-08-12 |
Bonner-Ferraby Phoebe W |
Autoantibody detection systems and methods
|
US20100143194A1
(en)
*
|
2008-12-08 |
2010-06-10 |
Electronics And Telecommunications Research Institute |
Microfluidic device
|
JP2012517594A
(ja)
|
2009-02-06 |
2012-08-02 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法および組成物
|
US20120052512A1
(en)
|
2009-02-06 |
2012-03-01 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US9752191B2
(en)
|
2009-07-09 |
2017-09-05 |
The Scripps Research Institute |
Gene expression profiles associated with chronic allograft nephropathy
|
EP2462440B1
(de)
|
2009-08-07 |
2017-05-17 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
|
US20120264148A1
(en)
|
2009-08-07 |
2012-10-18 |
Dashurie Nezieri |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2011025917A1
(en)
|
2009-08-28 |
2011-03-03 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
NZ598741A
(en)
|
2009-09-18 |
2013-07-26 |
Astute Medical Inc |
Methods and composition for diagnosis and prognosis of renal injury and renal failure by performing assays to detect metalloproteinase inhibitor 4 on a body fluid sample
|
NZ619883A
(en)
|
2009-09-21 |
2014-11-28 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
NZ600160A
(en)
|
2009-11-07 |
2014-05-30 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
JP2013510322A
(ja)
|
2009-11-07 |
2013-03-21 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
SG181563A1
(en)
|
2009-12-08 |
2012-07-30 |
Abbott Gmbh & Co Kg |
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
|
WO2012040592A1
(en)
|
2010-09-24 |
2012-03-29 |
Astute Medical, Inc. |
Methods and compositions for the evaluation of renal injury using hyaluronic acid
|
CN104698161A
(zh)
|
2009-12-20 |
2015-06-10 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
JP5998055B2
(ja)
|
2010-02-05 |
2016-09-28 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
CA2789147A1
(en)
|
2010-02-05 |
2011-08-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CN102791885B
(zh)
|
2010-02-05 |
2015-09-09 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
US9029093B2
(en)
|
2010-02-26 |
2015-05-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2011162820A1
(en)
|
2010-06-23 |
2011-12-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2555871B1
(de)
|
2010-04-07 |
2021-01-13 |
Biosensia Patents Limited |
Flusssteuerungsvorrichtung für assays
|
WO2011129382A1
(en)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Methods and reagents for diagnosing rheumatoid arthritis
|
EP3339859A1
(de)
|
2010-06-23 |
2018-06-27 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
AU2011269775B2
(en)
|
2010-06-23 |
2015-01-15 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
ES2629850T3
(es)
|
2010-07-19 |
2017-08-16 |
Otago Innovation Limited |
Biomarcadores de señal
|
US10557856B2
(en)
|
2010-09-24 |
2020-02-11 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Biomarkers of renal injury
|
CA2811438A1
(en)
|
2010-10-07 |
2012-04-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
EP2646822B1
(de)
|
2010-11-29 |
2017-11-01 |
Alere San Diego, Inc. |
Verfahren zur diagnose und risikovorhersage bei herzversagen
|
WO2012094658A2
(en)
|
2011-01-08 |
2012-07-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2012102963A1
(en)
|
2011-01-26 |
2012-08-02 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Urine biomarkers for prediction of recovery after acute kidney injury : proteomics
|
EP2668499A4
(de)
|
2011-01-29 |
2015-05-27 |
Astute Medical Inc |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz
|
ES2721907T3
(es)
|
2011-08-26 |
2019-08-06 |
Astute Medical Inc |
Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
|
WO2013078253A1
(en)
|
2011-11-22 |
2013-05-30 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2013086359A1
(en)
|
2011-12-08 |
2013-06-13 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CA2855840C
(en)
|
2011-12-14 |
2023-08-29 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
EP2791175A2
(de)
|
2011-12-14 |
2014-10-22 |
Abbvie Deutschland GmbH & Co. KG |
Zusammensetzung und verfahren zur diagnose und behandlung von durch eisenmangel bedingten erkrankungen
|
CA2802669C
(en)
|
2012-01-20 |
2020-08-11 |
Ortho-Clinical Diagnostics, Inc. |
Assay device having uniform flow around corners
|
RU2644337C2
(ru)
|
2012-01-27 |
2018-02-08 |
Эббви Дойчланд Гмбх Унд Ко. Кг |
Композиции и способы диагностики и лечения заболеваний, ассоциированных с дегенерацией нейритов
|
IN2014MN01760A
(de)
|
2012-02-27 |
2015-07-03 |
Astute Medical Inc |
|
CA2866220A1
(en)
|
2012-03-13 |
2013-09-19 |
Abbvie Inc. |
Method for selecting or identifying a subject for v1b antagonist therapy
|
EP2828282B1
(de)
|
2012-03-20 |
2017-12-27 |
Otago Innovation Limited |
Biomarker
|
WO2013152047A1
(en)
|
2012-04-02 |
2013-10-10 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of sepsis
|
EP2841945A4
(de)
|
2012-04-24 |
2016-04-27 |
Astute Medical Inc |
Verfahren und zusammensetzungen zur diagnose und prognose von schlaganfall oder anderen hirnläsionen
|
EP2875347B1
(de)
|
2012-07-23 |
2019-05-08 |
Astute Medical, Inc. |
Verfahren zur diagnose von sepsis
|
EP2882869A4
(de)
|
2012-08-07 |
2016-04-20 |
Jackson H M Found Military Med |
Prostatakrebs-genexpressionsprofile
|
US20150241415A1
(en)
|
2012-08-11 |
2015-08-27 |
Astute Medical, Inc. |
Evaluating renal injury using hyaluronic acid
|
CA2833532C
(en)
|
2012-11-15 |
2021-10-26 |
Ortho-Clinical Diagnostics, Inc. |
Quality/process control of a lateral flow assay device based on flow monitoring
|
EP2925884B1
(de)
|
2012-11-27 |
2018-01-31 |
Luxembourg Institute of Health |
Zusammensetzungen und verfahren zur bewertung von herzfehlern
|
EP3361255B1
(de)
|
2013-01-17 |
2020-03-11 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
AU2014239248B2
(en)
|
2013-03-14 |
2017-02-23 |
Alere San Diego, Inc. |
6-Acetylmorphine analogs, and methods for their synthesis and use
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
US20160146832A1
(en)
|
2013-06-05 |
2016-05-26 |
Lakhmir S. Chawla |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
US10183988B2
(en)
|
2013-06-07 |
2019-01-22 |
Duke University |
Anti-Complement factor H antibodies
|
BR112016002685A2
(pt)
|
2013-08-07 |
2018-01-30 |
Astute Medical Inc |
ensaios para timp2 que apresentam melhor desempenho em amostras biológicas
|
KR102322057B1
(ko)
|
2013-08-23 |
2021-11-05 |
리아타 파마슈티컬즈, 아이엔씨. |
바독솔론 메틸 또는 이의 유사체를 이용한 내피 기능장애의 치료 및 예방 방법
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
EP3693738A1
(de)
|
2013-09-20 |
2020-08-12 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von appendizitis und differenzierung von ursachen für bauchschmerzen
|
MX2016005834A
(es)
|
2013-11-06 |
2016-11-17 |
Astute Medical Inc |
Ensayos para igfbp7 con mejor rendimiento en muestras biológicas.
|
US10300108B2
(en)
|
2013-12-03 |
2019-05-28 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
JP2017506910A
(ja)
|
2013-12-30 |
2017-03-16 |
ザ ヘンリー エム. ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド |
前立腺癌に関連したゲノム再編成及び該ゲノム再編成の使用方法
|
EP3146076A4
(de)
|
2014-05-22 |
2018-05-09 |
The Scripps Research Institute |
Mit subklinischer nierentransplantatabstossung assoziierte genexpressionsprofile
|
AU2015263998A1
(en)
|
2014-05-22 |
2016-12-08 |
Northwestern University |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
EP3146077A4
(de)
|
2014-05-22 |
2018-05-02 |
The Scripps Research Institute |
Molekulare gewebesignaturen von nierentransplantatabstossungen
|
US11104951B2
(en)
|
2014-05-22 |
2021-08-31 |
The Scripps Research Institute |
Molecular signatures for distinguishing liver transplant rejections or injuries
|
US10443100B2
(en)
|
2014-05-22 |
2019-10-15 |
The Scripps Research Institute |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
EA201790696A1
(ru)
|
2014-10-20 |
2017-10-31 |
Астьют Медикал, Инк. |
Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности
|
US10473671B2
(en)
|
2014-12-18 |
2019-11-12 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
WO2016164854A1
(en)
|
2015-04-09 |
2016-10-13 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
CN107735147A
(zh)
|
2015-05-12 |
2018-02-23 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断和预后的方法和组合物
|
EP3308166A4
(de)
|
2015-06-11 |
2019-05-15 |
Astute Medical, Inc. |
Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
|
WO2016205740A1
(en)
|
2015-06-17 |
2016-12-22 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
|
CA2992139A1
(en)
|
2015-07-10 |
2017-01-19 |
West Virginia University |
Markers of stroke and stroke severity
|
EP3458439B1
(de)
|
2016-05-18 |
2021-12-08 |
Alere San Diego, Inc. |
2-ethyliden-1,5-dimethyl-3,3-diphenylpyrrolidin-analoga sowie methoden zu deren synthese und verwendung
|
CA3026502A1
(en)
|
2016-06-06 |
2017-12-14 |
Astute Medical, Inc. |
Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
US20180106800A1
(en)
|
2016-10-03 |
2018-04-19 |
Abbott Laboratories |
Methods of assessing uch-l1 status in patient samples
|
US11633411B2
(en)
|
2016-10-04 |
2023-04-25 |
University Of Maryland, Baltimore |
Methods of treating sepsis using anti-sepsis lipid A (ASLA) based therapeutics
|
NZ753546A
(en)
|
2016-11-08 |
2022-10-28 |
Reata Pharmaceuticals Holdings Llc |
Methods of treating alport syndrome using bardoxolone methyl or analogs thereof
|
WO2018132702A1
(en)
|
2017-01-12 |
2018-07-19 |
Astute Medical, Inc. |
Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement
|
CN110678751A
(zh)
|
2017-03-09 |
2020-01-10 |
克利拉生物技术有限公司 |
针对细胞衰老的生物标志物
|
CA3052513A1
(en)
|
2017-03-23 |
2018-09-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
EP3610268A1
(de)
|
2017-04-15 |
2020-02-19 |
Abbott Laboratories |
Verfahren zur unterstützung bei der hyperakuten diagnose und bestimmung von traumatischen hirnverletzungen in einem menschlichen patienten mit frühbiomarkern
|
JP7080899B2
(ja)
|
2017-04-28 |
2022-06-06 |
アボット・ラボラトリーズ |
同じヒト対象に由来する少なくとも2つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
US20210025875A1
(en)
|
2017-05-07 |
2021-01-28 |
Astute Medical, Inc. |
Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy
|
CA3078725A1
(en)
|
2017-05-25 |
2018-11-29 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
AU2018275236A1
(en)
|
2017-05-30 |
2019-10-31 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I
|
US11169159B2
(en)
|
2017-07-03 |
2021-11-09 |
Abbott Laboratories |
Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
|
AU2018378084A1
(en)
|
2017-12-09 |
2020-05-14 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
|
BR112019028254A2
(pt)
|
2017-12-09 |
2020-07-14 |
Abbott Laboratories |
métodos para ajudar no diagnóstico e avaliação de um paciente que sofreu uma lesão ortopédica e que sofreu ou pode ter sofrido uma lesão na cabeça, tal como uma lesão cerebral traumática (lct) leve, usando a proteína ácida fibrilar glial (gfap) e/ou a hidrolase carbóxi-terminal da ubiquitina l1 (uch-l1)
|
US11891439B2
(en)
|
2017-12-28 |
2024-02-06 |
Astute Medical, Inc. |
Antibodies and assays for CCL14
|
EP3732489A1
(de)
|
2017-12-29 |
2020-11-04 |
Abbott Laboratories |
Neuartige biomarker und verfahren zur diagnose und bewertung von traumatischer hirnverletzung
|
WO2019213619A1
(en)
|
2018-05-04 |
2019-11-07 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
EP3846797A4
(de)
|
2018-09-04 |
2022-06-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Verwendung von delta-tocotrienol zur behandlung von krebs
|
US11287429B2
(en)
|
2018-09-25 |
2022-03-29 |
Siemens Healthcare Diagnostics Inc. |
Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurements
|
US20200209250A1
(en)
|
2018-12-28 |
2020-07-02 |
Abbott Laboratories |
Direct detection of single molecules on microparticles
|
WO2020144535A1
(en)
|
2019-01-08 |
2020-07-16 |
Aduro Biotech Holdings, Europe B.V. |
Methods and compositions for treatment of multiple myeloma
|
EP3931573A1
(de)
|
2019-03-01 |
2022-01-05 |
Abbott Laboratories |
Verfahren zur vorhersage von schwerwiegenden kardiovaskulären ereignissen bei patienten mit koronararterienerkrankung
|
EP4136459A1
(de)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Verfahren, komplexe und kits zum nachweis oder zur bestimmung einer menge eines ss-coronavirus-antikörpers in einer probe
|
CA3177913A1
(en)
|
2020-05-09 |
2021-11-18 |
Deborah FERGUSON |
Methods of treating covid-19 using bardoxolone methyl or analogs thereof
|
EP4158352A1
(de)
|
2020-06-01 |
2023-04-05 |
Loop Diagnostics, S.L. |
Verfahren und kit zum frühen nachweis von sepsis
|
WO2022031804A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
US11988671B2
(en)
|
2020-08-04 |
2024-05-21 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting SARS-CoV-2
|
US20220170948A1
(en)
|
2020-12-01 |
2022-06-02 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
EP4259155A1
(de)
|
2020-12-11 |
2023-10-18 |
Reata Pharmaceuticals Holdings, LLC |
Synthetische triterpenoide zur verwendung in der therapie
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
BR112023024169A2
(pt)
|
2021-05-18 |
2024-02-06 |
Abbott Lab |
Métodos para avaliar lesão cerebral em um indivíduo pediátrico
|
EP4356129A1
(de)
|
2021-06-14 |
2024-04-24 |
Abbott Laboratories |
Verfahren zur diagnose oder unterstützung der diagnose von hirnverletzungen durch akustische energie, elektromagnetische energie, überdruckwelle und/oder explosionswind
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
CA3232176A1
(en)
|
2021-09-30 |
2023-04-06 |
Beth MCQUISTON |
Methods and systems of diagnosing brain injury
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
US20230213536A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
WO2023212294A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Angiopoietin-related protein 7-specific antibodies and uses thereof
|
WO2023212293A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Complement factor h related 4-specific antibodies and uses thereof
|
WO2023212298A1
(en)
|
2022-04-29 |
2023-11-02 |
Broadwing Bio Llc |
Bispecific antibodies and methods of treating ocular disease
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|